Pharma

Drug manufacturers are challenged to balance the prices charged for their products with their investments in R&D. Data used across the pharmaceutical supply chain is vulnerable and needs to be protected from cyber threats. New drug discoveries are underway, promising to save lives or help consumers manage illness, yet escalating drug costs has resulted in narrow formularies and abuses in acquisition and distribution. At HLTH, attendees will have a chance to add their voice to these discussions on efficiency, costs, development trials, and avoiding drug abuse and addiction.

 

Register Now